Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)

Clinical trial NCT06887062 · RECRUITING

Trial details

NCT number: NCT06887062
Sponsor: University of Edinburgh
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Large Vessel Vasculitis Giant Cell Arteritis (GCA)Takayasu Arteritis

Start date: 2025-03-21
Primary completion: 2027-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.